Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of critical care

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jcrc.2012.06.001PMID 22884529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of Costs Associated with Tolvaptan-Mediated Hospital Length of Stay Reduction Among US Patients with the Syndrome of Inappropriate Antidiuretic Hormone Secretion, Based on SALT-1 and SALT-2 Trials

  2012cited by this paper
• Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial

  2012cited by this paper
• Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.

  2011cited by this paper
• Hyponatremia in patients with traumatic brain injury: etiology, incidence, and severity correlation.

  2011cited by this paper
• Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion.

  2011cited by this paper
• Incidence and prognosis of dysnatremias present on ICU admission

  2010influential reference
• Hyponatremia

  2010cited by this paper
• The syndrome of inappropriate antidiuretic hormone: current and future management options.

  2010cited by this paper
• Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit

  2010cited by this paper
• Oral tolvaptan is safe and effective in chronic hyponatremia.

  2010cited by this paper
• Serum Sodium Predicts Prognosis in Critically Ill Cirrhotic Patients

  2010cited by this paper
• Characterization of intensive care unit acquired hyponatremia and hypernatremia following cardiac surgery

  2010cited by this paper
• Treatment of hyponatremia

  2010cited by this paper
• Efficacy and Safety of Oral Conivaptan, a Vasopressin-Receptor Antagonist, Evaluated in a Randomized, Controlled Trial in Patients With Euvolemic or Hypervolemic Hyponatremia

  2009cited by this paper
• Hyponatremia treatment guidelines 2007: expert panel recommendations.

  2009influential reference
• Mortality after hospitalization with mild, moderate, and severe hyponatremia.

  2009cited by this paper
• The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units

  2008influential reference
• Diagnosis and management of hyponatremia in acute illness

  2008cited by this paper
• Assessment of the Efficacy and Safety of Intravenous Conivaptan in Euvolemic and Hypervolemic Hyponatremia

  2007cited by this paper
• Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.

  2006cited by this paper
• AVP receptor antagonists as aquaretics: review and assessment of clinical data.

  2006cited by this paper
• Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.

  2006cited by this paper
• Disorders of body water homeostasis in critical illness.

  2006influential reference
• Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

  2006cited by this paper
• Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia.

  2006cited by this paper
• Body water homeostasis: clinical disorders of urinary dilution and concentration.

  2006cited by this paper
• Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management.

  2006cited by this paper
• Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients

  2005cited by this paper
• Treatment of electrolyte disorders in adult patients in the intensive care unit.

  2005influential reference
• Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.

  2004cited by this paper
• Dysnatremias in the critical care setting.

  2004influential reference
• Red book : pharmacy's fundamental reference

  2004cited by this paper
• [Incidence, causes and prognostic factors of hyponatremia in intensive care].

  2003influential reference
• Delirium in the Intensive Care Unit: Occurrence and Clinical Course in Older Patients

  2003cited by this paper
• Incidence, étiologies et facteurs pronostiques de l'hyponatrémie en réanimation

  2003cited by this paper
• The impact of delirium in the intensive care unit on hospital length of stay

  2001cited by this paper
• Predisposing factors for delirium in the surgical intensive care unit

  2001cited by this paper
• Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide.

  2001cited by this paper
• Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU).

  2001cited by this paper
• Hyponatremia.

  2000cited by this paper
• Diuretic complications.

  2000cited by this paper
• 5-year treatment of the chronic syndrome of inappropriate secretion of ADH with oral urea.

  1993cited by this paper
• Incidence and etiology of hyponatremia in an intensive care unit.

  1990cited by this paper
• Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin.

  1985cited by this paper
• Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone.

  1981cited by this paper
• Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients.

  1980cited by this paper

• Safety and Efficacy of Tolvaptan for Acute Refractive Hyponatremia Associated with Traumatic Brain Injury

  2025cites this paper
• Effect of Pituitary-Target Gland Axis on RAAS in the Context of COVID-19

  2025cites this paper
• The Effects of Sodium-glucose Cotransporter 2 Inhibitors on Serum Sodium in Patients With Type 2 Diabetes

  2025cites this paper
• V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology

  2023cites this paper
• Clinical and Etiological Profile of Hyponatremia in ICU Patients at Tertiary Care Hospital

  2023cites this paper
• A Conspectus of Euvolemic Hyponatremia, Its Various Etiologies, and Treatment Modalities: A Comprehensive Review of the Literature

  2023cites this paper
• Hyponatremia Related to Neurocritical Care: Focus on Diagnosis and Therapy. A Systematic review.

  2022cites this paper
• The diagnosis and management of acute hyponatraemia in critical care.

  2022cites this paper
• Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective

  2021cites this paper
• Frequency of Electrolyte Disorders and Its Effect On Mortality Among Children Admitted In Pediatric Intensive Care Unit

  2021cites this paper
• Disorders of electrolyte and acid-base and its impact association in intensive care patients

  2021cites this paper
• Frequency of Hyponatremia and Its Outcome in Critically Ill Patients

  2021influential citation
• Stress and the "extended" autonomic system.

  2021cites this paper
• GAMBARAN STATUS ELEKTROLIT PASIEN YANG DIRAWAT DI INTENSIVE CARE UNIT (ICU)

  2021cites this paper
• The extended autonomic system, dyshomeostasis, and COVID-19

  2020cites this paper
• Etiologies, Clinical Manifestations, and Factors Associated with Severe Symptomatic Hyponatremia among Hospitalized Hyponatremia Patients

  2020cites this paper
• Stroke vs. SIADH: A case of symptomatic hyponatremia secondary to SIADH in association with COVID-19 infection

  2020cites this paper
• A STUDY OF ELECTROLYTES IMBALANCE IN MECHANICALLY VENTILATED PATIENTS

  2020cites this paper
• A Furosemide Excretion Stress Test Predicts Mortality in Mice After Sepsis and Outperforms the Furosemide Stress Test During Vasopressin Administration

  2020cites this paper
• Effect of antitubercular treatment on serum electrolyte and bicarbonate among pulmonary tuberculosis patients in tertiary care Hospital: An observational study

  2019cites this paper
• Vaptans and the Treatment of Hyponatremia

  2019cites this paper
• Admission serum sodium and potassium levels predict survival among critically ill patients with acute kidney injury: a cohort study

  2019cites this paper
• A CASE REPORT ON THE ‘SILENT EPIDEMIC’ OF CHLORTHALIDONE INDUCED HYPONATREMIA; ROLE OF CLINICAL PHARMACIST

  2018cites this paper
• Sodium and Water Balance

  2018cites this paper
• Profile of Hyponatremia in Patients admitted into Medical ICU

  2018cites this paper
• Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients

  2017cites this paper
• A systematic literature search and review of sodium concentrations of body fluids
.

  2016cites this paper
• Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients

  2016cites this paper
• L’hyponatrémie chez le patient cérébrolésé en soins intensifs : étiologie et prise en charge

  2016cites this paper
• Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage: Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies*

  2016cites this paper
• Human Sulfotransferases Enhance the Cytotoxicity of Tolvaptan.

  2016cites this paper
• Endokrine Störungen beim Intensivpatienten

  2015cites this paper
• Initial experience of use of tolvaptan in critically ill patients with fluid overload

  2015cites this paper
• Patterns of treatment and correction of hyponatremia in intensive care unit patients.

  2015cites this paper
• Mechanisms of tolvaptan-induced toxicity in HepG2 cells.

  2015influential citation
• Hyponatremia in the neurocritical care patient: An approach based on current evidence.

  2015cites this paper
• Prevalence, risk factors, and short-term consequences of traumatic brain injury-associated hyponatremia.

  2015cites this paper
• Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?

  2015cites this paper
• Hyponatremia in the neurocritical care patient: An approach based on current evidence.

  2015cites this paper
• Anesthetic and critical care challenges in massive chyle leak following robotic surgery: a special case report

  2015cites this paper
• Chapter 69 – Postoperative Intensive Care Management in Adults

  2015cites this paper
• Characteristics of Persistent Hyponatremia and Tolvaptan Treatment in Nine Hospitalized Patients With Advanced HIV Disease

  2014cites this paper
• Post‐operative hyponatraemic encephalopathy: a successful outcome despite hypoxia

  2014cites this paper
• The Use of Vaptans in Clinical Endocrinology

  2013cites this paper
• Clinical review: the use of vaptans in clinical endocrinology.

  2013cites this paper
• Management of hyponatremia in the ICU.

  2013cites this paper
• Comparison of the Serum Electrolyte Levels among Patients Died and Survived in the Intensive Care Unit

  2012cites this paper
• Hyponatremia Due to Pulmonary Tuberculosis: Review of 200 Cases

  2012cites this paper
• Hyponatremia As A Predictor of Death in End Stage Liver Disease Patients

  2011cites this paper